Indefinite Delivery Contract SPE2D224D0007
Award Date
8/13/24
Last Date to Order
8/12/29
Federal Agency
Medical Supply Chain
Awardee
Exelan Pharmaceuticals Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Indefinite Delivery Contract (IDC) with award ID 36E79725D0002 was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Exelan Pharmaceuticals Inc. for the provision of a wide range of branded and generic pharmaceutical products and services. This single-award IDC has a ceiling value of $4,792,297.44 and a period of performance running through December 19, 2025.
Exelan Pharmaceuticals, a foreign-owned for-profit pharmaceutical company, will supply prescription...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company. The single-award IDC, valued at up to $6,984,109.81, has an ultimate completion date of February 11, 2029.
Under this contract, Exelan Pharmaceuticals will provide a variety of generic pharmaceutical products to the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons through...
This Indefinite Delivery Contract (IDC) was awarded by the National Acquisition Center, a civilian agency within the Department of Veterans Affairs (VA), to Exelan Pharmaceuticals Inc. The single-award contract has a ceiling value of $32,360,809.00 and a period of performance from October 31, 2020 to October 30, 2025, with four one-year option periods.
The contract is for the supply of Topiramate tablets in various dosages and package sizes to the VA, Department of Defense, Bureau of Prisons,...
The federal contract IDV award described is a single-award Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The contract has a ceiling value of $28,235,184.10 and a period of performance through January 31, 2028.
The contract is intended to provide a national supply source for various pharmaceutical products, including but not limited to ibuprofen,...
The federal contract IDV award SPE2D219D0070 was granted to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The IDV is a single-award indefinite delivery contract with a ceiling value of $45,158,494.05 and an ultimate completion date of May 28, 2024. Exelan Pharmaceuticals, a key supplier of generic and branded pharmaceutical products to various federal healthcare agencies, will deliver a diverse range of pharmaceutical items...
This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The single-award contract has a ceiling value of $12,802,166.10 and a period of performance from March 14, 2022 to March 13, 2023, with four one-year option periods.
The contract is for the delivery of Ramipril capsules in various dosages and package sizes to...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company that specializes in providing branded and generic medications to U.S. government agencies. The $5.59 million contract, with a performance period from June 2021 to June 2026, is to manufacture and distribute alendronate sodium tablets in 35mg and 70mg dosages for purchase by the Department of Defense (DoD) and Department of...
The Indefinite Delivery Contract (IDC) SPE2D219D0075 was awarded by the Defense Logistics Agency (DLA) to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The contract has a ceiling value of $40,400,530.45 and a period of performance through June 30, 2024.
The contract aims to establish a national supply source for Budesonide Inhalation Suspension in various dosages, to be purchased by the Department of Defense, Bureau of Prisons,...
The Indefinite Delivery Contract (IDC) SPE2D222D0147 was awarded by the Defense Logistics Agency (DLA) to Mylan Pharmaceuticals Inc., a for-profit manufacturer of pharmaceutical goods. The single-award IDC has a total ceiling value of $10,967,220.00 and a period of performance running through September 13, 2027.
Under this contract, Mylan will provide the DLA, Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons, and Indian Health Service with a variety of...
The federal contract IDV award is for an Indefinite Delivery Contract (IDC) with a single prime contractor, Exelan Pharmaceuticals Inc., to supply a variety of lisinopril tablets in different strengths and package sizes to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons, and Indian Health Service.
The contract has a 1-year base period and four 1-year option periods, with a total ceiling value of $40,480,225.15. Exelan, a foreign-owned for-profit...